• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国接受结直肠癌筛查的最高年龄限制。

Acceptance on colorectal cancer screening upper age limit in South Korea.

机构信息

Graduate School of Cancer Science and Policy, National Cancer Center, Goyang-si 10408, South Korea.

National Cancer Control Institute, National Cancer Center, Goyang-si 10408, South Korea.

出版信息

World J Gastroenterol. 2020 Jul 21;26(27):3963-3974. doi: 10.3748/wjg.v26.i27.3963.

DOI:10.3748/wjg.v26.i27.3963
PMID:32774070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7385558/
Abstract

BACKGROUND

The Korea National Cancer Screening Program currently provides screening for colorectal cancer (CRC) for adults older than 50 years with no upper age limit. In general, people are likely to only pay attention to the benefits of cancer screening and to neglect its risks. Most consider the benefits of cancer screening as being far greater than the risks and are unaware that any potential benefits and harms can vary with age.

AIM

To report acceptance of an upper age limit for CRC screening and factors associated therewith among cancer-free individuals in Korea.

METHODS

The present study analyzed data from the Korea National Cancer Screening Survey 2017, a nationally representative random sample of 4500 Korean individuals targeted for screening for the five most common types of cancer. A total of 1922 participants were included in the final analysis. The baseline characteristics of the study population are presented as unweighted numbers and weighted proportions. Both univariate and multivariate logistic regression models were developed to examine factors related with acceptance of an upper age limit for CRC screening; subgroup analysis was also applied.

RESULTS

About 80% (1554/1922) of the respondents agreed that CRC screening should not be offered for individuals older than 80 years. Specifically, those who had never been screened for CRC had the highest acceptance rate (91%). Overall, screening history for CRC [screened by both fecal occult blood test and colonoscopy, adjusted odds ratio (aOR) = 0.33, 95%CI: 0.22-0.50] and other cancers (aOR = 0.55, 95%CI: 0.34-0.87), as well as a family history of cancer (aOR = 0.66, 95%CI: 0.50-0.87), were negatively associated with acceptance of an upper age limit for CRC screening. In contrast, metropolitan residents (aOR = 1.86, 95%CI: 1.29-2.68) and people who exercised regularly (aOR = 1.42, 95%CI: 1.07-1.89) were more likely to accept an upper age limit. After subgrouping, we found gender, marital status, and lifetime smoking history among never-screened individuals and residential region, family history of cancer, and physical activity among never-screened individuals to be associated with acceptance of an upper age limit.

CONCLUSION

This study describes acceptance of an upper age limit for CRC screening and factors associated with it, and provides perspectives that should be considered, in addition to scientific evidence, when developing population-based cancer screening policies and programs.

摘要

背景

韩国国家癌症筛查计划目前为 50 岁以上的成年人提供结直肠癌(CRC)筛查,没有年龄上限。一般来说,人们可能只关注癌症筛查的益处,而忽视其风险。大多数人认为癌症筛查的益处远远大于风险,并且不知道任何潜在的益处和危害可能因年龄而异。

目的

报告韩国无癌症个体对 CRC 筛查的年龄上限的接受程度及其相关因素。

方法

本研究分析了 2017 年韩国国家癌症筛查调查的数据,该调查是对全国 4500 名针对五种最常见癌症进行筛查的韩国人的代表性随机抽样。共有 1922 名参与者纳入最终分析。研究人群的基线特征以未加权数字和加权比例表示。使用单变量和多变量逻辑回归模型来检验与接受 CRC 筛查的年龄上限相关的因素;还进行了亚组分析。

结果

约 80%(1554/1922)的受访者认为不应对 80 岁以上的个体进行 CRC 筛查。具体而言,从未接受过 CRC 筛查的人接受率最高(91%)。总体而言,CRC 筛查史[粪便潜血试验和结肠镜检查均进行,调整后的优势比(aOR)=0.33,95%CI:0.22-0.50]和其他癌症(aOR=0.55,95%CI:0.34-0.87),以及癌症家族史(aOR=0.66,95%CI:0.50-0.87)与接受 CRC 筛查的年龄上限呈负相关。相比之下,大都市居民(aOR=1.86,95%CI:1.29-2.68)和经常锻炼的人(aOR=1.42,95%CI:1.07-1.89)更有可能接受年龄上限。在亚组分析中,我们发现从未筛查过的人群中,性别、婚姻状况和终生吸烟史,以及从未筛查过的人群中,居住地、癌症家族史和身体活动与接受年龄上限相关。

结论

本研究描述了对 CRC 筛查的年龄上限的接受程度及其相关因素,并提供了在制定基于人群的癌症筛查政策和计划时,除了科学证据之外,还应考虑的观点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad6/7385558/f2b7b408e485/WJG-26-3963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad6/7385558/f2b7b408e485/WJG-26-3963-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fad6/7385558/f2b7b408e485/WJG-26-3963-g001.jpg

相似文献

1
Acceptance on colorectal cancer screening upper age limit in South Korea.韩国接受结直肠癌筛查的最高年龄限制。
World J Gastroenterol. 2020 Jul 21;26(27):3963-3974. doi: 10.3748/wjg.v26.i27.3963.
2
Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.目标人群对捷克共和国结直肠癌筛查障碍和促进因素的观点。
World J Gastroenterol. 2019 Mar 7;25(9):1132-1141. doi: 10.3748/wjg.v25.i9.1132.
3
Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea.韩国粪便潜血试验和结肠镜检查用于结直肠癌筛查的采用阶段。
Cancer Res Treat. 2018 Apr;50(2):416-427. doi: 10.4143/crt.2017.075. Epub 2017 May 10.
4
[Compliance rate of screening colonoscopy and its associated factors among high-risk populations of colorectal cancer in urban China].[中国城市结直肠癌高危人群筛查结肠镜检查的依从率及其相关因素]
Zhonghua Yu Fang Yi Xue Za Zhi. 2018 Mar 6;52(3):231-237. doi: 10.3760/cma.j.issn.0253-9624.2018.03.004.
5
Disparities in the Participation Rate of Colorectal Cancer Screening by Fecal Occult Blood Test among People with Disabilities: A National Database Study in South Korea.残疾人粪便潜血试验筛查结直肠癌参与率的差异:韩国国家数据库研究。
Cancer Res Treat. 2020 Jan;52(1):60-73. doi: 10.4143/crt.2018.660. Epub 2019 May 7.
6
Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006-2013).韩国国家结直肠癌筛查计划(2006-2013 年)粪便潜血试验结果。
Sci Rep. 2017 Jun 5;7(1):2804. doi: 10.1038/s41598-017-03134-9.
7
Adherence to follow-up after a positive fecal occult blood test in an organized colorectal cancer screening program in Korea, 2004-2008.2004-2008 年韩国在有组织的结直肠癌筛查项目中对粪便潜血检测阳性后的随访依从性。
J Gastroenterol Hepatol. 2012 Jun;27(6):1070-7. doi: 10.1111/j.1440-1746.2011.06944.x.
8
Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.多次粪便免疫化学检测受试者的间期结直肠癌发病率。
Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5.
9
[Rates on the acceptance of colonoscopy, fecal immunochemical test and a novel risk-adapted screening approach in the screening programs of colorectal cancer as well as related associated factors].[结肠镜检查、粪便免疫化学检测及一种新型风险适应性筛查方法在结直肠癌筛查项目中的接受率以及相关影响因素]
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1655-1661. doi: 10.3760/cma.j.cn112338-20200227-00196.
10
Perceptions of colorectal cancer screening and recommendation behaviors among physicians in Korea.韩国医生对结直肠癌筛查的认知及推荐行为。
BMC Cancer. 2017 Dec 16;17(1):860. doi: 10.1186/s12885-017-3881-5.

引用本文的文献

1
Assessment of Psychosocial Correlates and Associated Factors of Colorectal Cancer Screening among Southwestern Saudi Population: A Cross-Sectional Study.沙特西南部人群结直肠癌筛查的社会心理相关因素及相关因素评估:一项横断面研究。
Healthcare (Basel). 2023 Oct 21;11(20):2791. doi: 10.3390/healthcare11202791.
2
Developing and validating polygenic risk scores for colorectal cancer risk prediction in East Asians.开发和验证东亚人群结直肠癌风险预测的多基因风险评分。
Int J Cancer. 2022 Nov 15;151(10):1726-1736. doi: 10.1002/ijc.34194. Epub 2022 Jul 21.

本文引用的文献

1
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016.《韩国癌症统计:2016 年发病率、死亡率、生存率和流行率》
Cancer Res Treat. 2019 Apr;51(2):417-430. doi: 10.4143/crt.2019.138. Epub 2019 Mar 18.
2
Patient Attitudes Toward Individualized Recommendations to Stop Low-Value Colorectal Cancer Screening.患者对停止低价值结直肠癌筛查的个体化建议的态度。
JAMA Netw Open. 2018 Dec 7;1(8):e185461. doi: 10.1001/jamanetworkopen.2018.5461.
3
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
4
Colorectal Cancer Screening-Who, How, and When?结直肠癌筛查——对象、方法及时机?
Clin Endosc. 2018 Jan;51(1):37-49. doi: 10.5946/ce.2017.141. Epub 2018 Jan 31.
5
Systematic review of colorectal cancer screening guidelines for average-risk adults: Summarizing the current global recommendations.系统评价结直肠癌筛查指南在一般风险成年人中的应用:总结当前全球建议。
World J Gastroenterol. 2018 Jan 7;24(1):124-138. doi: 10.3748/wjg.v24.i1.124.
6
Individualized Approach to Cancer Screening in Older Adults.老年人癌症筛查的个体化方法。
Clin Geriatr Med. 2018 Feb;34(1):11-23. doi: 10.1016/j.cger.2017.09.002. Epub 2017 Oct 14.
7
Screening for Colorectal Cancer: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.结直肠癌筛查:美国预防服务工作组的更新证据报告和系统评价。
JAMA. 2016 Jun 21;315(23):2576-94. doi: 10.1001/jama.2016.3332.
8
Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement.结直肠癌筛查:美国预防服务工作组推荐声明。
JAMA. 2016 Jun 21;315(23):2564-2575. doi: 10.1001/jama.2016.5989.
9
Population-Based Colonoscopy Screening for Colorectal Cancer: A Randomized Clinical Trial.基于人群的结肠镜检查用于结直肠癌筛查:一项随机临床试验。
JAMA Intern Med. 2016 Jul 1;176(7):894-902. doi: 10.1001/jamainternmed.2016.0960.
10
Socioeconomic Disparities in Colorectal Cancer Screening in Korea: A Nationwide Cross-Sectional Study.韩国结直肠癌筛查中的社会经济差异:一项全国性横断面研究。
Medicine (Baltimore). 2015 Sep;94(39):e1368. doi: 10.1097/MD.0000000000001368.